Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Alternate Programmed Cell Death Signaling in Antiviral Host Defense [[electronic resource] /] / edited by Edward S. Mocarski, Pratyusha Mandal
| Alternate Programmed Cell Death Signaling in Antiviral Host Defense [[electronic resource] /] / edited by Edward S. Mocarski, Pratyusha Mandal |
| Autore | Mocarski Edward S |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (175 pages) |
| Disciplina | 616.9101 |
| Altri autori (Persone) | MandalPratyusha |
| Collana | Current Topics in Microbiology and Immunology |
| Soggetto topico |
Immunology
Medical microbiology Virology Medical Microbiology |
| ISBN | 3-031-45278-X |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Programmed Necrosis in Host Defense -- ZBP1/DAI-dependent Cell Death Pathways in Influenza A Virus Immunity and Pathogenesis -- Pyroptosis in Antiviral Immunity -- Manipulation of Host Cell Death Pathways by Herpes Simplex Virus -- Subversion of Programed Cell Death by Poxviruses -- Cell Killing by Reovirus: Mechanisms and Consequences -- Outcomes of RIP kinase signaling during neuroinvasive viral infection. |
| Record Nr. | UNINA-9910770261503321 |
Mocarski Edward S
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chikungunya Virus : Advances in Biology, Pathogenesis, and Treatment / / edited by Chioma M. Okeoma
| Chikungunya Virus : Advances in Biology, Pathogenesis, and Treatment / / edited by Chioma M. Okeoma |
| Edizione | [1st ed. 2016.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 |
| Descrizione fisica | 1 online resource (X, 197 p. 39 illus., 31 illus. in color.) |
| Disciplina | 616.9101 |
| Soggetto topico |
Virology
Epidemiology Vaccines Vaccine |
| ISBN | 9783319429588 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Clinical Syndrome and Therapy -- Host Response and Mechanisms of Subversion of Chikungunya -- Epidemiological History of Chikungunya Virus -- Vaccines Against Chikungunya Virus Infection -- Function of Chikungunya Virus Structural Proteins -- Functions of Chikungunya Virus Nonstructural Proteins -- Interaction of Chikungunya Virus with the Mosquito Vector -- Chikungunya Virus Entry and Replication -- Chikungunya Virus-Induced Autophagy and Apoptosis -- Chikungunya Virus Pathogenesis -- Restriction Factors and Chikungunya Virus. |
| Record Nr. | UNINA-9910155329003321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical virology manual / / editor in chief, Michael J. Loeffelholz ; editors, Richard L. Hodinka , Stephen A. Young, Benjamin A. Pinsky
| Clinical virology manual / / editor in chief, Michael J. Loeffelholz ; editors, Richard L. Hodinka , Stephen A. Young, Benjamin A. Pinsky |
| Edizione | [Fifth edition.] |
| Pubbl/distr/stampa | Washington, District of Columbia : , : ASM Press, , [2016] |
| Descrizione fisica | 1 online resource (xv, 622 pages) : illustrations |
| Disciplina | 616.9101 |
| Soggetto topico | Diagnostic virology |
| ISBN |
1-68367-318-2
1-68367-069-8 1-55581-915-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Section I: General topics in clinical virology -- Virus taxonomy / Steven J. Drews -- Quality control/quality assurance / Matthew J. Bankowski -- Regulatory compliance / Linoj Samuel -- Laboratory safety / Sue C. Kehl -- Laboratory Design / Matthew J. Binniker -- Section II: Laboratory procedures for detecting viruses -- Specimen selection, collection, transport, processing, and storage / Reeti Khare and Thomas E. Grys -- Primary isolation of viruses / Marie L. Landry and Diane S. Leland -- Antigen detection methods (IFA, solid-phase immunoassays) / Diane S. Leland and Ryan F. Rlich -- serologic methods (IFA, IA, WB, HA, HI, Neut, IgM-specific methods) / Dongxiang Xia, Debra A. Wadford, Christopher P. Preas, and David P. Schnurr -- Nucleic acid extraction in diagnostic virology / Raymond H. Widen -- Nucleic acid amplification by polymerase chain reaction / Ana María Cárdenas and Kevin Alby -- Isothermal nucleic acid amplification methods / Harald H. Kessler and Evelyn Stelzl -- Quantitative molecular methods / Natalie N. Whitfield and Donna M. Wolk -- Signal amplification methods / Yun (Wayne) Wang -- Sequencing methods / Joanne Bartkus -- Phenotypic and genotypic antiviral susceptibility testing / Martha T. Van Der Beek and Eric C. J. Claas -- Point-of-care diagnostic virology / James J. Dunn and Lakshmi Chandramohan -- Future technology / Erin Mcelvania Tekipe and Carey-Ann D. Burnham -- Section III: Viral pathogens -- Respiratory viruses / Christine Robinson -- Enteroviruses and parechoviruses / M. Steven Oberste and Mark A. Pallansch -- Measles, mumps, and rubella viruses / William J. Bellini, Joseph P. Icenogle, and Carole J. Hickman -- Gastrointestinal viruses / Michael D. Bowen -- Hepatitis A and E viruses / Gilberto Vaughan and Michael A. Purdy -- Hepatitis B and D viruses / Rebecca T. Horvat -- Hepatitis C virus / David Hillyard and Melanie Mallory -- Herpes simplex viruses and Varicella-Zoster virus / Mark Prichard -- Cytomegalovirus / Preeti Pancholi and Stanley I. Martin -- Epstein-Barr virus / Derrick Chen and Belinda Yen-Lieberman -- Human herpesviruses 6, 7, and 8 / Sheila C. Dollard and Tim Karnauchow -- Human papillomaviruses / Susan Novak-Weekley and Robert Pretorius -- Human polyomaviruses / Rebecca J. Rockett, Michael D. Nissen, Theo P. Sloots, and Seweryn Bialasiewicz -- Parvovirus / Richard S. Buller -- Poxviruses / Ashley V. Kondas and Victoria A. Olson -- Rabies virus / Robert J. Rudd -- Arboviruses / Laura D. Kramer, Elizabeth B. Kauffman, and Norma P. Tavakoli -- Animal-borne viruses / Gregory J. Berry, Michael J. Loeffelholz, and Gustavo Palacios -- Human immunodeficiency virus and human T-lymphotropic viruses / Jörg Schüpbach -- Chlamydiae / Bobbie Van Der Pol and Charlotte A. Gaydos -- Human virome / Matthew C. Ross, Nadim J. Ajami, and Joseph F. Petrosino -- Human susceptibility and response to viral diseases / Ville Peltola and Jorma Ilonen -- Appendices: Reference virology laboratories -- A. Reference virology laboratories at the Centers for Disease Control and Prevention / Roberta B. Carey -- B. U.S. state and local public health laboratories / Jane Getchell -- C. International reference laboratories/laboratory systems / Ariel Suarez and Cristina Videla. |
| Record Nr. | UNINA-9910148575503321 |
| Washington, District of Columbia : , : ASM Press, , [2016] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Confronting Emerging Zoonoses : The One Health Paradigm / / edited by Akio Yamada, Laura H. Kahn, Bruce Kaplan, Thomas P. Monath, Jack Woodall, Lisa Conti
| Confronting Emerging Zoonoses : The One Health Paradigm / / edited by Akio Yamada, Laura H. Kahn, Bruce Kaplan, Thomas P. Monath, Jack Woodall, Lisa Conti |
| Edizione | [1st ed. 2014.] |
| Pubbl/distr/stampa | Tokyo : , : Springer Japan : , : Imprint : Springer, , 2014 |
| Descrizione fisica | 1 online resource (253 p.) |
| Disciplina |
579.3
610 616.9 616.9101 |
| Soggetto topico |
Virology
Bacteriology Infectious diseases Infectious Diseases |
| ISBN | 4-431-55120-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Part I The Importance of a One Health Approach to Emerging Zoonotic Diseases -- 1 The Origin of Human Pathogens -- 2 Drivers of Emerging Zoonotic Infectious Diseases -- 3 Biodiversity and Emerging Zoonoses -- Part II Understanding Zoonotic Diseases Through A One Health Perspective -- 4 Hantaviruses -- 5 Enterohemorrhagic E. Coli Infections -- 6 Bartonellosis: A One Health Perspective -- 7 A One Health Approach to Influenza Pandemics -- Part III The Successes and Challenges of Implementing One Health -- 8 One Health: From Concept to Practice -- 9 Field Epidemiology and One Health: Thailand’s Experience -- 10 One Health and Food Safety -- 11 The Clinical Biomedical Research Advances Achievable Utilizing One Health Principles -- 12 One Health Successes and Challenges. |
| Record Nr. | UNINA-9910298344203321 |
| Tokyo : , : Springer Japan : , : Imprint : Springer, , 2014 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Coronavirus disease - COVID-19 / / Nima Rezaei, editor
| Coronavirus disease - COVID-19 / / Nima Rezaei, editor |
| Edizione | [1st ed. 2021.] |
| Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
| Descrizione fisica | 1 online resource (XX, 964 p. 168 illus., 121 illus. in color.) |
| Disciplina | 616.9101 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico |
Epidemiology
Immunology Virology |
| ISBN | 3-030-63761-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Introduction on Coronavirus Disease (COVID-19) Pandemic: The Global Challenge (Nima Rezaei, Saboura Ashkevarian, Mahsa Keshavarz Fathi, Sara Hanaei, Zahra Kolahchi, Seyedeh-Sanam Ladi Seyedian, Elham Rayzan, Mojdeh Sarzaeim, Aida Vahed, Kawthar Mohamed, Sarah Momtazmanesh, Negar Moradian, Zahra Rahimi Pirkoohi, Noosha Sameeifar, Mahsa Yousefpour, Sepideh Sargoli, Saina Adiban, Aida Vahed, Niloufar Yazdanpanah, Heliya Ziaei, Amene Saghazadeh) -- Chapter 2. Coronaviruses: What Should We Know About the Characteristics of Viruses? (Wei Ji) -- Chapter 3. Ecology and Evolution of Betacoronaviruses (Eduardo Rodríguez-Román, Adrian J. Gibbs) -- Chapter 4. The Epidemiologic Aspects of COVID-19 Outbreak: Spreading Beyond Expectations (Sara Hanaei, Farnam Mohebi, Maziar Moradi-Lakeh, Parnian Jabbari, Surinder Kumar Mehta, Liudmyla S. Kryvenko, Livio Luongo, Loďc Dupré, Nima Rezaei) -- Chapter 5. The Incubation Period of COVID-19: Current Understanding and Modeling Technique (Char Leung) -- Chapter 6. Coronavirus: Pure Infectious Disease or Genetic Predisposition (Farzaneh Darbeheshti, Hassan Abolhassani, Mohammad Bashashati, Saeid Ghavami, Sepideh Shahkarami, Samaneh Zoghi, Sudhir Gupta, Jordan S. Orange, Hans D. Ochs, Nima Rezaei) -- Chapter 7. Genetic Polymorphisms in the Host and COVID-19 Infection (Joris R. Delanghe, Marc L. De Buyzere, Marijn M. Speeckaert) -- Chapter 8. How COVID-19 Has Globalized: Unknown Origin, Rapid Transmission, and the Immune System Nourishment (Amene Saghazadeh, Nima Rezaei) -- Chapter 9. Potential Anti-viral Immune Response Against COVID-19: Lessons Learned from SARS-CoV (Mahzad Akbarpour, Laleh Sharifi, Amir Reza Safdarian, Pooya Farhangnia, Mahdis Borjkhani, Nima Rezaei) -- Chapter 10. COVID-19 and Cell Stress (Abdo A Elfiky, Ibrahim M Ibrahim, Fatma G Amin, Alaa M Ismail, Wael M Elshemey) -- Chapter 11. Clinical Manifestations of COVID-19 (Mahsa Eskian, Nima Rezaei) -- Chapter 12. Pediatrics and COVID-19 (Tuna Toptan, Sandra Ciesek, Sebastian Hoehl) -- Chapter 13. Geriatrics and COVID-19 (Mona Mirbeyk, Amene Saghazadeh, Nima Rezaei) -- Chapter 14. Coronavirus Diseases in Pregnant Women, the Placenta, Fetus, and Neonate (David A. Schwartz, Amareen Dhaliwal) -- Chapter 15. COVID-19 in Patients with Hypertension (Thiago Quinaglia, Mahsima Shabani, Nima Rezaei) -- Chapter 16. COVID-19 and Cardiovascular Diseases (Babak Geraiely, Niloufar Samiei, Parham Sadeghipour, Azita Haj Hossein Talasaz, Seyedeh Hamideh Mortazavi, Roya Sattarzadeh Badkoubeh) -- Chapter 17. How Prevalent Is Cancer in Confirmed Cases with Coronaviruses and Severe Acute Respiratory Syndromes? (Maryam Fotouhi, Elham Samami, Sahar Mohseni, Amir Nasrollahizadeh, Mohammad Haddadi, Mona Mirbeyk, Amene Saghazadeh, Nima Rezaei) -- Chapter 18. COVID-19 in Patients with Cancer (Ali Nowroozi, Sepideh Razi, Kamal Kant Sahu, Fabio Grizzi, Jann Arends, Mahsa Keshavarz-Fathi, Nima Rezaei) -- Chapter 19. COVID-19 and Tropical Infection: Complexity and Concurrence (Pathum Sookaromdee, Viroj Wiwanitkit) -- Chapter 20. Neurologic Manifestations of COVID-19 (Farnaz Delavari, Farnaz Najmi Varzaneh, Nima Rezaei) -- Chapter 21. Autoimmune Processes Involved in Organ System Failure Following Infection with SARS-CoV-2 (Steven E. Kornguth, Robert J. Hawley) -- Chapter 22. Clinical and Laboratory Predictors of Severity, Criticality, and Mortality in COVID-19: A Multisystem Disease (Bahareh Gholami, Samira Gholami, Amir Hossein Loghman, Behzad Khodaei, Simin Seyedpour, Nasrin Seyedpour, Amene Saghazadeh, Nima Rezaei) -- Chapter 23. Diagnostic Tests for COVID-19 (Tung Phan, Kristin Nagaro) -- Chapter 24. The Role of Medical Imaging in COVID-19 (Houman Sotoudeh, Masoumeh Gity) -- Chapter 25. Therapeutic Development in COVID-19 (Chan Yang, Yuan Huang, Shuwen Liu) -- Chapter 26. Immune-based Therapy for COVID-19 (Abdolreza Esmaeilzadeh, Davood Jafari, Safa Tahmasebi, Reza Elahi, Elnaz Khosh) -- Chapter 27. Ventilatory Support in Patients with COVID-19 (Paolo Maria Leone, Matteo Siciliano, Jacopo Simonetti, Angelena Lopez, Tanzira Zaman, Francesco Varone, Luca Richeldi) -- Chapter 28. Nutrition and Immunity in COVID-19 (Marjan Moallemian Isfahani, Zahra Emam-Djomeh, Idupulapati M. Rao, Nima Rezaei) -- Chapter 29. Dietary Supplements for COVID-19 (Gerard E. Mullin, Berkeley Limektkai, Lin Wang, Patrick Hanaway, Loren Marks, Edward Giovannucci) -- Chapter 30. Photobiomodulation and Antiviral Photodynamic Therapy in COVID-19 Management (Reza Fekrazad, Sohrab Asefi, Maryam Pourhajibagher, Farshid Vahdatinia, Sepehr Fekrazad, Abbas Bahador, Heidi Abrahamse, Michael R Hamblin) -- Chapter 31. The COVID-19 Vaccine Landscape (Till Koch, Anahita Fathi, Marylyn M. Addo) -- Chapter 32. Prevention of COVID-19: Preventive Strategies for General Population, Health Care Settings, and Various Professions (Shirin Moossavi, Kelsey Fehr, Hassan Maleki, Simin Seyedpour, Mahdis Keshavarz-Fath, Farhad Tabasi, Mehrdad Heravi, Rayka Sharifian, Golnaz Shafiei, Negin Badihian, Roya Kelishadi, Shahrzad Nematollahi, Majid Almasi, Saskia Popescu, Mahsa Keshavarz-Fathi, Nima Rezaei) -- Chapter 33. Pharmacist Role and Pharmaceutical Care during the COVID-19 Pandemic (Pedro Amariles, Mónica Ledezma-Morales, Andrea Salazar-Ospina, Jaime Alejandro Hincapié-García) -- Chapter 34. Impact of COVID-19 on Dentistry (Arghavan Tonkaboni, Mohammad Hosein Amirzade-Iranaq, Heliya Ziaei, Amber Ather) -- Chapter 35. The Implications of COVID-19 to Ophthalmology (Tracy H.T. Lai, Emily W.H. Tang, Kenneth K.W. Li) -- Chapter 36. Challenges of Cellular therapy during COVID-19 Pandemic (Kamal Kant Sahu, Sikander Ailawadhi, Natalie Malvik, Jan Cerny) -- Chapter 37. COVID-19 Amid Rumours and Conspiracy Theories: The Interplay between Local and Global Worlds (Inayat Ali) -- Chapter 38. Exploration of the Epidemiological and Emotional Impact of Quarantine and Isolation during COVID‐19 Pandemic (Helia Mojtabavi, Nasirudin Javidi, Anne-Frédérique Naviaux, Pascal Janne, Maximilien Gourdin, Mahsa Mohammadpour, Amene Saghazadeh, Nima Rezaei) -- Chapter 39. The Main Sources and Potential Effects of COVID-19-related Prejudice and Discrimination (Piotr Rzymski, Hanna Mamzer, Michał Nowicki) -- Chapter 40. Potential mechanisms of COVID-19-related psychological problems and mental disorders (Chunfeng Xiao) -- Chapter 41. Mental Health in Health Professionals in the COVID-19 Pandemic (Antonia Bendau, Andreas Ströhle, Moritz Bruno Petzold) -- Chapter 42. Treatment of Patients with Mental Illness Amid a Global COVID-19 Pandemic (Ankit Jain, Kamal Kant Sahu, Paroma Mitra) -- Chapter 43. A Shift in Medical Education During the COVID-19 Pandemic (Farida Nentin1, Nagaraj Gabbur, Adi Katz) -- Chapter 44. Reopening Schools After a Novel Coronavirus Surge (Dan Li, Elizabeth Z. Lin, Marie A. Brault, Julie Paquette, Sten H. Vermund, Krystal J. Godri Pollitt) -- Chapter 45. COVID-19 and Its Impact on Tourism Industry (Dimitrios G. Lagos, Panoraia Poulaki, Penny Lambrou) -- Chapter 46. COVID-19 and Its Global Economic Impact (Zahra Kolahchi, Manlio De Domenico, Lucina Q. Uddin, Valentina Cauda, Igor Grossmann, Lucas Lacasa, Giulia Grancini, Morteza Mahmoudi, Nima Rezaei) -- Chapter 47. Retrieval and Investigation of Data on SARS-CoV-2 and COVID-19 Using Bioinformatics Approach (Muhamad Fahmi, Viol Dhea Kharisma, Arif Nur Muhammad Ansori, Masahiro Ito) -- Chapter 48. Answering the Challenge of COVID-19 Pandemic through Innovation and Ingenuity (Kathryn Clare Kelley, Jonathan Kamler, Manish Garg, Stanislaw P. Stawicki) -- Chapter 49. COVID-19 Pandemic: The Influence of Culture and Lessons for Collaborative Activities (Linda Simon Paulo, George M. Bwire, Xingchen Pan, Tianyue Gao, Amene Saghazadeh, Chungen Pan) -- Chapter 50. A Borderless Solution Is Needed for A Borderless Complexity, Like COVID-19, The Universal Invader (Kawthar Mohamed, Rangarirai Makuku, Eduardo Rodríguez-Román, Aram Pascal Abu Hejleh, Musa Joya, Mariya Ivanovska, Sara A. Makka, Md Shahidul Islam, Nesrine Radwan, Attig-Bahar Faten, Chunfeng Xiao, Leander Marquez, Nima Rezaei) -- Chapter 51. Socialization During The COVID-19 Pandemic: The Role of Social and Scientific Networks During Social Distancing (Sara Momtazmanesh, Noosha Samieefar, Lucina Q. Uddin, Timo Ulrichs, Roya Kelishadi, Vasili Roudenok, Elif Karakoc-Aydiner, Deepak B. Salunke, Jan L. Nouwen, Juan Carlos Aldave Becerra, Duarte Nuno Vieira, Ekaterini Goudouris, Mahnaz Jamee, Morteza Abdullatif Khafaie, Morteza Shamsizadeh, Mohammad Rasoul Golabchi, Alireza Samimiat, Donya Doostkamel, Alireza Afshar, Mohammad Amin Khazeei Tabari, Melika Lotfi, Reza Yari Boroujeni, Niloofar Rambod, Anzhela Stashchak, Alla Volokha, Dainius Pavalkis, André Pereira, Amir Hamzah Abdul Latiff, Rauf Baylarov, Bagher Amirheidari, Mojtaba Hedayati, Antonio Condino-Neto, Nima Rezaei) -- Chapter 52. Interdisciplinary Approaches to COVID-19 (Negar Moradian, Marjan Moallemian, Farnaz Delavari, Constantine Sedikies, Carlos A. Camargo, Jr., Pedro J. Torres, Armin Sorooshian, Saeid Paktinat Mehdiabadi, Juan J. Nieto, Stephane Bordas, Hamid Ahmadieh, Mohammad Abdollahi, Michael R. Hamblin, Frank W. Sellke, Jack Cuzick, Bozkurt Biykem, Michael Schreiber, Babak Eshrati, Georg Perry, Ali Montazeri, Ali Akbar Saboury, Roya Kelishadi, Amirhossein Sahebkar, Ali A. Moosavi-Movahed, Hassan Vatandoost, Mofid Gorji-Bandpy, Bahram Mobasher, Nima Rezaei) -- Chapter 53. Health and Art (HEART): Integrating Science and Art to Fight COVID-19 (Nima Rezaei, Aida Vahed, Heliya Ziaei, Negin Bashari, Saina Adiban Afkham, Fatemeh Bahrami, Sara Bakhshi, Alireza Ghanadan, Atlasi Ghanadan, Nastaran Hosseini, Pariya Kafi, Reihaneh Khalilianfard, Kawthar Mohammed, Sepideh Sargoli, Kosar Tavasoli, Mahya Zare, Amene Saghazadeh). |
| Record Nr. | UNINA-9910484978503321 |
| Cham, Switzerland : , : Springer, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Dengue and Zika: Control and Antiviral Treatment Strategies / / edited by Rolf Hilgenfeld, Subhash G. Vasudevan
| Dengue and Zika: Control and Antiviral Treatment Strategies / / edited by Rolf Hilgenfeld, Subhash G. Vasudevan |
| Edizione | [1st ed. 2018.] |
| Pubbl/distr/stampa | Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 |
| Descrizione fisica | 1 online resource (XIII, 375 p. 99 illus., 70 illus. in color.) |
| Disciplina | 616.9101 |
| Collana | Advances in Experimental Medicine and Biology |
| Soggetto topico | Virology |
| ISBN | 981-10-8727-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter 1. Arboviruses on the rise -- Chapter 2. Historical perspective of arboviruses in Mozambique and its implication for current and future epidemics -- Chapter 3. Reliable serological testing for the diagnosis of emerging infectious diseases -- Chapter 4. Flaviviral RNA structures and their role in replication and immunity -- Chapter 5. The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections -- Chapter 6. Structures of Zika virus E & NS1: relations with virus infection and host immune responses -- Chapter 7. Plugging the leak – is dengue a case of aseptic shock with NS1 at its center -- Chapter 8. Entry & NS1 as drug targets -- Chapter 9. The dengue virus replication complex: from RNA replication to protein-protein interactions to evasion of innate immunity -- Chapter 10. Crystal structure of Zika virus NS2B-NS3 protease -- Chapter 11. The transactions of NS3 and NS5 in Dengue viral RNA replication -- Chapter 12. Establishment and application of flavivirus replicons -- Chapter 13. Strategies towards protease inhibitors for emerging flaviviruses -- Chapter 14. Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from fragment screening and structure-guided design -- Chapter 15. Nuclear cytoplasmic trafficking of dengue non-structural protein 5 as a target for antivirals -- Chapter 16. Animal Models for Dengue and Zika Vaccine Development -- Chapter 17 Understandingthe human T cell response to dengue virus -- Chapter 18. Regulation and function of NK and T cells during dengue virus infection and vaccination -- Chapter 19. Structural insights into the broad-spectrum antiviral target Endoplasmic Reticulum alpha glucosidase II -- Chapter 20. Mechanisms of antiviral activity of iminosugars against dengue virus -- Chapter 21. Countering Zika Virus: The USAMRIID Response -- Chapter 22 Dengue Antiviral Development: A Continuing Journey -- Chapter 23 An industry perspective on dengue drug discovery and development -- Chapter 24. The use of Wolbachia by the Eliminate Dengue program to interrupt transmission of Aedes Aegypti transmitted viruses -- Chapter 25 Seroepidemiological studies of Arboviruses in Africa. |
| Record Nr. | UNINA-9910298418703321 |
| Singapore : , : Springer Singapore : , : Imprint : Springer, , 2018 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fields virology / editors-in-chief, David M. Knipe, Peter M. Howley ; associate editors, Diane E. Griffin ... [et al.]
| Fields virology / editors-in-chief, David M. Knipe, Peter M. Howley ; associate editors, Diane E. Griffin ... [et al.] |
| Edizione | [5th ed.] |
| Pubbl/distr/stampa | Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, 2007 |
| Descrizione fisica | 2 v. : ill. ; 28 cm + 1 cd-rom |
| Disciplina |
576.64
616.9101 |
| Soggetto non controllato | Virologia |
| ISBN | 978-0-7817-6060-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-990009132420403321 |
| Philadelphia : Wolters Kluwer Health/Lippincott Williams & Wilkins, 2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fields virology / Bernard N. Fields, David M. Knipe
| Fields virology / Bernard N. Fields, David M. Knipe |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | New York : Raven Press, c1990 |
| Descrizione fisica | 2 v. (xix, 1340 p.) : ill. ; 29 cm |
| Disciplina | 616.9101 |
| Altri autori (Persone) |
Fields, Bernard N.
Knipe, David M.author |
| Soggetto topico |
Virology
Virus Diseases |
| ISBN | 0881675520 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISALENTO-991003472499707536 |
| New York : Raven Press, c1990 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. del Salento | ||
| ||
The Future of HIV-1 Therapeutics : Resistance Is Futile? / / edited by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman
| The Future of HIV-1 Therapeutics : Resistance Is Futile? / / edited by Bruce E. Torbett, David S. Goodsell, Douglas D. Richman |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 |
| Descrizione fisica | 1 online resource (257 p.) |
| Disciplina |
610
616.9 616.9041 616.9101 |
| Collana | Current Topics in Microbiology and Immunology |
| Soggetto topico |
Drug resistance
Virology Infectious diseases Drug Resistance Infectious Diseases |
| ISBN | 3-319-18518-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | HIV Therapy Looking Towards the Future -- Computational challenges of structure-based approaches applied to HIV -- Nucleocapsid Protein: A Desirable Target For Future Therapies Against HIV-1 -- HIV-1 integrase multimerization as a therapeutic target -- Targeting HIV transcription: The quest for a functional cure -- Targeting the HIV RNA Genome: High-Hanging Fruit Only Needs a Longer Ladder -- HIV-1 Gag: An Emerging Target for Antiretroviral Therapy -- The Triple Threat of HIV-1 Protease Inhibitors -- Illustrations of the HIV Life Cycle. |
| Record Nr. | UNINA-9910298294303321 |
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Global Virology II - HIV and NeuroAIDS / / edited by Paul Shapshak, Andrew J. Levine, Brian T. Foley, Charurut Somboonwit, Elyse Singer, Francesco Chiappelli, John T. Sinnott
| Global Virology II - HIV and NeuroAIDS / / edited by Paul Shapshak, Andrew J. Levine, Brian T. Foley, Charurut Somboonwit, Elyse Singer, Francesco Chiappelli, John T. Sinnott |
| Edizione | [1st ed. 2017.] |
| Pubbl/distr/stampa | New York, NY : , : Springer New York : , : Imprint : Springer, , 2017 |
| Descrizione fisica | 1 online resource (XII, 1067 p. 48 illus., 15 illus. in color.) |
| Disciplina | 616.9101 |
| Soggetto topico |
Virology
Neurosciences Immunology Vaccines Vaccine |
| ISBN | 1-4939-7290-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Forward -- Preface -- Multidisciplinary Approach to HIV/AIDS: Historical Perspective -- Global Issues in NeuroAIDS -- HIV-1 related Central Nervous System Diseases: Pathogenesis, Diagnosis, and Treatment – An Indian Scenario -- HIV-1 Diversity in Brazil -- HIV and SIV Evolution -- Human Brain Imaging in HIV and NeuroAIDS -- HIV Neuroinvasion.-Neuropathology of HIV-1 Disease -- HIV-related Peripheral Nervous System Illness -- The Role of Early Life Programming in Vulnerability and Resilience in Relation to HIV -- Neurocognition in Viral Suppressed HIV-Infected Children -- Psychiatric Comorbidities in HIV-Infection -- Toward an Iterative Approach to Preventing HIV Risk Among Young MSM -- NeuroAIDS in Drug Abusers - Associations with Oral Manifestations -- Socioepidemiology of Injection Drug Users in Miami and HIV-1B Envelope (V1-V5) Genetic Diversity: A Preliminary Study -- The persistence of HIV associated neurocognitive disorder (HAND) in the era of combined antiretroviral therapy (cART) -- Antiretroviral Therapy - Brain Penetration -- Molecular Mechanisms of Cognitive Impairment in Patients with HIV Infection: Application of Bioinformatics and Data-Mining -- Genetic, Epigenetic, and Transcriptomic Studies of NeuroAIDS -- NeuroAIDS: A Review of Gene Expression in Neurons, Astrocytes and Oligodendrocytes -- Neuronal Apoptotic Pathways in HIV Associated Dementia, Alzheimer’s Disease, Parkinson’s Disease, and Huntington's Disease -- Clinical Relevance of Humanized Mice -- HIV and Stroke -- Hepatitis C and HIV Neurological Implications -- Central Nervous System Reactivation of Chagas Disease in Immuno-compromised Patients with HIV/AIDS -- Central Nervous System Tuberculosis -- Neurosyphilis and HIV infection -- Orthopoxviruses and Human Disease -- Opportunistic Neurologic Infections in Patients Infected with Human Immunodeficiency Virus -- Zika Virus and HIV/AIDS -- Global Convergent Translational Science for Neuro-Involvement in Ebola Viral Disease: Lessons Learned from Neuro-AIDS -- Sequence Accuracy in Primary Databases: A case study on HIV-1B -- Amyloidogenic Pattern Prediction of HIV-1 Proteins -- On the Potential for Multiscale Oscillatory Behavior in HIV -- Short oligo-peptide T-cell epitopes in HIV-1/AIDS vaccine development: Current status, design, promises and challenges -- HIV-1 Envelope (ENV) GP160 trimer protein complex SPIKE as a recombinant macro-molecular assembly vaccine component candidate – Current opinion -- Gene Therapy Blueprints for NeuroAIDS -- Biostatistical Concerns in HIV Research. |
| Record Nr. | UNINA-9910253957803321 |
| New York, NY : , : Springer New York : , : Imprint : Springer, , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
